Departamento de Producción Animal, Instituto Nacional de Tecnología Agropecuaria (INTA), Estación Experimental Agropecuaria (EEA) Balcarce, RN 226 Km 73.3, (07620) Balcarce, Buenos Aires, Argentina.
Poult Sci. 2019 Jun 1;98(6):2422-2431. doi: 10.3382/ps/pez003.
Salmonellosis caused by Salmonella Enteritidis is a widespread zoonosis and poultry products are an important source of infection. This study was carried out to evaluate the protection of different vaccination schedules in layers using a live commercial attenuated Salmonella Enteritidis vaccine based on strain Sm24/Rif12/Ssq (AviPro® Salmonella Vac E, ELANCO) during rearing and egg production. Three hundred and fifty Salmonella-free chickens were distributed into 7 vaccinated groups and 1 unvaccinated group. Different vaccination schedules were performed combining either 1, 2, or 3 oral gavage doses. Chickens from Group A, B, and C were vaccinated once, either at the first day, at 7 or 16 wk old, respectively. Chickens from Group D were vaccinated twice-at the first day and 7 wk old. Chickens from Group E were vaccinated twice-at the first day and 16 wk old. Chickens from Group F were vaccinated twice-at 7 and 16 wk old. Chickens from Group G were vaccinated 3 times, following the manufacturer's recommendation: at the first day, 7 and 16 wk old. Chickens from Group H remained unvaccinated. Five challenge trials numbered 1 to 5 were carried out at 8, 12, 16, 29, and 55 wk old, respectively. After challenge, chickens were sampled by cloacal swabbing and, after euthanasia, livers, ovaries, spleens, and cecal contents were cultured to isolate S. Enteritidis. Additionally, eggs were collected after challenge and cultured to isolate S. Enteritidis on egg shells (Trials 4 and 5). Protection against experimental infection with a virulent nalidixic acid resistant S. Enteritidis strain K285/94, was evaluated by measuring reduction of excretion, colonization, invasion into organs, eggshell contamination, and egg production. The live S. Enteritidis vaccine protected the hens by reducing S. Enteritidis excretion, isolation from organs, and egg contamination. Higher protection throughout laying period was afforded after administration of three vaccine doses during rearing period.
肠炎沙门氏菌引起的沙门氏菌病是一种广泛存在的人畜共患病,禽产品是感染的重要来源。本研究旨在评估在育雏和产蛋期使用基于菌株 Sm24/Rif12/Ssq 的活商业减毒肠炎沙门氏菌疫苗(AviPro® Salmonella Vac E,ELANCO)对蛋鸡进行不同免疫接种方案的保护效果。350 只无沙门氏菌鸡被分为 7 个免疫组和 1 个未免疫组。不同的免疫接种方案结合了 1、2 或 3 次口服灌胃剂量。A、B 和 C 组的鸡分别在第 1 天、7 周龄和 16 周龄时进行了一次免疫接种。D 组的鸡在第 1 天和 7 周龄时进行了两次免疫接种。E 组的鸡在第 1 天和 16 周龄时进行了两次免疫接种。F 组的鸡在 7 周龄和 16 周龄时进行了两次免疫接种。G 组的鸡按照制造商的建议进行了三次免疫接种:第 1 天、7 周龄和 16 周龄。H 组的鸡未进行免疫接种。在 8、12、16、29 和 55 周龄时分别进行了 5 次攻毒试验 1 至 5。攻毒后,通过直肠拭子取样,鸡安乐死后,取肝脏、卵巢、脾脏和盲肠内容物进行培养以分离肠炎沙门氏菌。此外,在攻毒后收集鸡蛋并在蛋壳上培养以分离肠炎沙门氏菌(试验 4 和 5)。通过测量排泄量、定植、器官侵袭、蛋壳污染和产蛋量的减少,评估了对强耐萘啶酸肠炎沙门氏菌 K285/94 株的实验感染的保护作用。肠炎沙门氏菌活疫苗通过减少肠炎沙门氏菌的排泄、从器官中分离出来和蛋壳污染来保护母鸡。在育雏期给予三次疫苗剂量后,整个产蛋期的保护效果更高。